Literature DB >> 15118393

Cutaneous plasmablastic lymphoma in an HIV-positive male: an unrecognized cutaneous manifestation.

P Häusermann1, N Khanna, M Buess, P H Itin, M Battegay, S Dirnhofer, S A Buechner.   

Abstract

Plasmablastic lymphoma (PBL) is a rare and relatively new entity originally described in HIV-infected individuals. This subset of Epstein-Barr-virus (EBV)-related non-Hodgkin lymphomas is now regarded as a distinct clinicopathological category of AIDS-associated lymphomas occurring preferentially in the oral cavity and showing a poor prognosis. We describe for the first time an EBV-associated PBL with an isolated cutaneous distribution on the lower extremities in an HIV-infected heterosexual male and point to the unique clinical, morphological and immunophenotypic characteristics of this lymphoma. The patient presented with fast growing solid and livid nodules on both legs. The large, blastic tumor cells showed the following immunophenotype: CD138+, CD45+, CD20-, CD10-, CD3-, CD30-, bcl-2-, bcl-6-, LMP-1- and EMA-. The proliferation fraction (Mib-1) was >90%. EBV association was demonstrated by in situ hybridization (EBV-encoded RNAs 1/2). Polymerase-chain-reaction-based DNA analysis demonstrated a clonal IgH rearrangement in the absence of a bcl-2/IgH translocation. PBL in HIV patients may occur not only in the oral cavity, but can probably involve any other organs including the skin. Copyright 2004 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15118393     DOI: 10.1159/000077324

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  6 in total

1.  Plasmablastic lymphoma of the oral cavity, a B cell-derived lymphoma associated with HIV infection: a case series.

Authors:  Olga Tsachouridou; Artemis Christoforidou; Symeon Metallidis; Maria Papaioannou; Panagiotis Kollaras; Alexandros Kolokotronis; Theofilos Chrysanthidis; Dimitrios Pilalas; Konstantinos Markou
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-02-17       Impact factor: 2.503

Review 2.  HIV infection and lymphoma.

Authors:  K L Grogg; R F Miller; A Dogan
Journal:  J Clin Pathol       Date:  2007-12       Impact factor: 3.411

3.  EBV and HIV-Related Lymphoma.

Authors:  Michele Bibas; Andrea Antinori
Journal:  Mediterr J Hematol Infect Dis       Date:  2009-12-29       Impact factor: 2.576

Review 4.  Cutaneous primary B-cell lymphomas: from diagnosis to treatment.

Authors:  Margarida Lima
Journal:  An Bras Dermatol       Date:  2015 Sep-Oct       Impact factor: 1.896

5.  Cutaneous plasmablastic lymphoma in an immunocompetent patient with long-term pyrimethamine use for essential thrombocythemia: a case report and literature review.

Authors:  Ing Soo Tiong; Magreet Strauss; Michael B Y Lau; Shingirai Chiruka
Journal:  Case Rep Hematol       Date:  2013-02-06

6.  Immunosuppression-associated primary cutaneous plasmablastic lymphoma secondary to romidepsin.

Authors:  Collin M Costello; Connor J Maly; Sam Snider; Kevin J Severson; David J DiCaudo; Allison C Rosenthal; Donald W Northfelt; William Rule; Fiona E Craig; Mark R Pittelkow; Aaron R Mangold
Journal:  JAAD Case Rep       Date:  2019-12-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.